Issue link: https://nebusinessmedia.uberflip.com/i/1484548
HARTFORDBUSINESS.COM | NOVEMBER 21, 2022 43 SPONSORED CONTENT A research center aimed at shaping the way millions of Americans receive rehabilitative medicine was opened today by Gaylord Specialty Health- care, a nonprofit rehabilitation-focused healthcare system. e Milne Institute for Healthcare Innova- tion is named for Carol and George Milne, Jr., Ph.D., whose historic $5 million gift has created a hub for accelerating world-class research, technology development and in- novation on Gaylord's Wallingford campus. With accreditations held by few around the world, Gaylord Specialty Healthcare is a national leader in the medical management and rehabilitation of patients recovering from devastating injuries or illnesses. e Milne Institute aims to leverage Gaylord's expertise in brain and spinal cord injuries, complex strokes, amputations and pulmo- nary diseases to conduct research and de- velop evidence-based practices and applied technologies with the potential to change lives around the world. "For more than 118 years, Gaylord has helped patients reclaim their lives," stated Sonja LaBarbera, President, and CEO of Gaylord Specialty Healthcare. "is is our purpose — to heal the human body and inspire longevity. We are driven by patients and motivated by practitioners who are pio- neers in therapy and experts in confronting life's most devastating moments." "e Milne Institute for Healthcare Inno- vation is our commitment to accelerate Gaylord's long history of research, develop assistive and universally designed technolo- gies to enhance recovery, advance the clin- ical practice of rehabilitation medicine, and ultimately minimize limitations," she said. "It is our goal that the Milne Institute for Healthcare Innovation will become a source of transformational discoveries that will redefine the standards of care." "We've set in motion a bold strategy to ac- celerate revolutionary approaches to some of the biggest challenges in modern rehabil- itative healthcare. And it takes leaders like Carol and George Milne who are equally as bold to invest in this plan," she said. "We cannot thank the Milnes enough for their generosity. We are incredibly grateful for their foresight and hands-on involve- ment with the creation of this transfor- mative vision." Dr. George Milne, retired Executive Vice President of Global Research and Development and President of Central Research at Pfizer, Inc., stated, "As a scientist and a biomedical researcher with a broad interest in patient-oriented outcomes, it is clear that Gaylord fills a unique niche that is not well-represented in our country. Gay- lord is and will be an important sentinel for both patients and medical innovators who seek to enhance the quality of care." "We strongly believe in Gaylord's proven potential to make a compelling difference in the world outcomes for patients," he con- tinued, "and a belief that there is a critical opportunity to create new advances that focus on the whole patient, particularly as the population ages and faces challenges such as COVID." About Gaylord Specialty Healthcare: Gaylord Specialty Healthcare is a rehabil- itation-focused, nonprofit health system headquartered in Wallingford, Connecticut, that provides inpatient and outpatient care for people at every point in their journey from illness or injury to maximum recovery. Gaylord Specialty Healthcare is anchored by Gaylord Hospital, a long-term acute care hospital, and includes Gaylord Outpatient Services and Gaylord Physical erapy for patients who require diagnosis and treat- ment on an outpatient basis. Together, these entities deliver a complete continuum of rehab care driven by technology, research, clinical experience, and human compassion. For more information visitwww.gaylord.org. Celebrating 120 Years of Caring Milne Institute for Healthcare Innovation opened by Gaylord Specialty Healthcare